Quantitative Systematic Strategies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-6,324
Closed -$220K 725
2020
Q3
$220K Buy
+6,324
New +$222K 0.04% 507
2017
Q3
Sell
-45,213
Closed -$1.44M 526
2017
Q2
$1.44M Buy
+45,213
New +$1.43M 0.37% 107
2016
Q2
Sell
-68,099
Closed -$1.94M 497
2016
Q1
$1.94M Buy
+68,099
New +$1.95M 0.75% 16
2015
Q3
Sell
-13,989
Closed -$445K 487
2015
Q2
$445K Buy
+13,989
New +$456K 0.1% 334
2015
Q1
Sell
-7,198
Closed -$214K 477
2014
Q4
$214K Buy
+7,198
New +$206K 0.09% 271

Other funds holding PFE

Quantitative Systematic Strategies's PFE Position: Q4 2020 in Review

Quantitative Systematic Strategies sold out of Pfizer (PFE) in Q4 2020, closing a stake of 6,324 shares — an estimated $220K sold.

Quantitative Systematic Strategies first reported a position in PFE in Q4 2014 and held it in 5 quarters. The position peaked at $1.94M in Q1 2016. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

  • Quantitative Systematic Strategies reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 6,324 Pfizer shares in Q4 2020, an estimated $220K.
  • Quantitative Systematic Strategies first reported a position in Pfizer in Q4 2014 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Pfizer position peaked at $1.94M in Q1 2016.
  • 2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2020, filed 9 Feb 2021.